- Home >
- Life Sciences >
- Biotechnology >
Biotechnology Industry Analysis and Statistics (since 2008 - p2)
All premium reports for Biotechnology Industry Analysis and Statistics (since 2008 - p2)
31-60 of 286 Premium Reports from 27 Publishers
Cell and Tissue Analysis Products: The Global Market
- $ 4 850
- September 2009
STUDY GOALS AND OBJECTIVESThis report, Cell and Tissue Analysis Products: The Global Market, provides a detailed analysis of the products and technologies that define the market space and summarizes the composition and dynamics of individual companies in the competitive environment. The study also i ...
Industries : Biomaterial
Competitor Analysis: VEGF and VEGF-R Agonists and Antagonists
- $ 750
- September 2009
Product description The present Competitive Intelligence Report about VEGF and VEGF-R agonists and antagonists provides a competitor evaluation in the field of VEGF and its receptor targeting molecules for treatment of cancer, AMD and for neuroprotection as of September 2009. Purchase of the down ...
Industries : Biotechnology, Pharmaceutical
Novo Nordisk A/S - SWOT Analysis
- $ 125
- September 2009
Datamonitor's Novo Nordisk A/S - SWOT Analysis company profile is the essential source for top-level company data and information. Novo Nordisk A/S - SWOT Analysis examines the company?s key business structure and operations, history and products, and provides summary analysis of its key revenue lin ...
Industries : Biotechnology
Competitor Analysis: Targeted Therapy of Hepatitis C
- $ 625
- August 2009
Product description The present Competitive Intelligence Report about Targeted Therapy of Hepatitis C provides a competitor evaluation in the field of specifically targeted antiviral therapeutics for hepatitis C (STAT-C) as of August 2009. Purchase of the downloadable pdf report includes a 6-month ...
Industries : Biotechnology, Pharmaceutical
Laboratory Testing Services in the US
- $ 730
- August 2009
INDUSTRY MARKET RESEARCH REPORTThis is the replacement for August 2009 edition of Laboratory Testing Services in the US report.Industry Market Research SynopsisThis Industry Market Research report provides a detailed analysis of the Laboratory Testing Services in the US industry, including key gro ...
Industries : Biotechnology, Diagnostics, Medical Equipment and Supply
Asia Pacific Biotechnology Market (2008-2012)
- $ 1 400
- August 2009
- 120 pages
The biotechnology market in Asia-Pacific region looks very lucrative from investment perspective as it has enjoyed double-digit growth in past few years. The industry is attracting more and more private investments in wake of immense growth opportunities and vast untapped biotech markets. Identifyin ...
Industries : Biotechnology
World Market for Biosimilars and the Potential for US Follow-on Biologics, The
- $ 3 700
- August 2009
Biosimilars, or generic biologic drugs, are marketed around the world but still restricted in the U.S. This may soon change, and Kalorama Information has released this timely study of the market in Europe and other areas in the world and the possibility of a U.S. Market in the near future. As part ...
Industries : Biotechnology
Biotechnological innovations in the pharmaceutical industry in Poland 2009: Development forecasts for biotechnology sector for 2009-2011
- $ 2 500
- August 2009
Report Description:Biotechnological innovations in the pharmaceutical industry in Poland 2009 provides a comprehensive overview of the biotechnology market in Poland. Covering major industry trends and events, it touches on both domestic and international occurrences that have significance to the Po ...
Industries : Biotechnology
Competitor Analysis: CHK and KSP/Eg5 Inhibitors
- $ 219
- August 2009
Product description The present Competitive Intelligence Report about checkpoint kinase (CHK) and kinesin spindle protein (KSP) or Eg5 inhibitors provides a competitor evaluation in the field of novel molecular entities inhibiting CHK or KS/Eg5 for treatment of cancer as of August 2009. Purchase ...
Industries : Biotechnology, Pharmaceutical
Competitor Analysis: Bcr-Abl and Src Kinase Inhibitors
- $ 250
- July 2009
Product description The present Competitive Intelligence Report about Bcr-Abl and Src Kinase Inhibitors provides a competitor evaluation in the field of novel molecular entities inhibiting Bcr-Abl and/or Src kinase for treatment of cancer as of July 2009. Purchase of the downloadable pdf repo ...
Industries : Biotechnology, Pharmaceutical
Competitor Analysis: PI3K-AKT-mTOR Inhibitors
- $ 625
- July 2009
Product description The present Competitive Intelligence Report about PI3K-AKT-mTOR Inhibitors provides a competitor evaluation in the field of novel molecular entities inhibiting members of the phosphatidyl-inositol-3 kinase (PI3K) / Akt / mammalian target of rapamycin (mTOR) pathway for treatme ...
Industries : Biotechnology, Pharmaceutical
Competitor Analysis: HDAC Inhibitors
- $ 500
- July 2009
Product description The present Competitive Intelligence Report about HDAC Inhibitors provides a competitor evaluation in the field of novel molecular entities inhibiting histone deacetylase for treatment of cancer and other diseases as of July 2009. Purchase of the downloadable pdf report includ ...
Industries : Biotechnology, Pharmaceutical
Competitor Analysis: IGF-1R Antagonists
- $ 313
- July 2009
Product description The present Competitive Intelligence Report about IGF-1R Antagonists provides a competitor evaluation in the field of novel molecular entities directed against the insulin-like growth factor-1 receptor (IGF-1R) or its ligands IGF-1 and IGF-2 for treatment of cancer as of July ...
Industries : Biotechnology, Pharmaceutical
Market Feasibility Report ? Japan Biotechnology Market
- $ 1 500
- July 2009
Although Japan still lags behind the United States, and much of Europe, in the development of its biotechnology sector, the country is making considerable effort to develop biotechnology as a major industry. As a result, the Japanese biotechnology industry has been making good progress in recent yea ...
Industries : Biotechnology
Biotechnology Statistics Almanac ? 2009
- $ 0
- July 2009
Biotechnology Statistics ? 2009 edition brings together the latest available economic and activity data on biotechnology and innovation. The results should provide a valuable source of information on biotechnology for policy makers, academics and business managers.The survey data provide results on ...
Industries : Biotechnology
Feasibility Report - Egypt Biotechology Laboratory Equipment Industry
- $ 600
- July 2009
Biotechnology was introduced in Egypt in 1990 and is rapidly picking up momentum. It is used for tissue culture of crops, genetic engineering, and diagnosis of tumors. Research related to transplants of kidneys, liver, and bone marrow is being developed and progressing rapidly. Egyptian scientists a ...
Industries : Biotechnology
US BioScience Industry- 2008
- $ 1 400
- July 2009
The biosciences are recognized globally as a key driver of modern economic progress, offering enormous potential for linking basic research innovations with new market opportunities. Advances in human, plant, and animal biosciences have led to the growth of companies in many areas, from drug develop ...
Industries : Biotechnology
Bioterrorism
- $ 3 950
- July 2009
This report analyzes the worldwide markets for Bioterrorism in Millions of US$. The report provides separate comprehensive analytics for the US, Europe, Asia, and Middle East. Annual forecasts are provided for each region for the period of 2001 through 2015. The report profiles 66 companies includin ...
Industries : Biotechnology
Proteomics: Technologies and Global Markets
- $ 4 850
- July 2009
REPORT HIGHLIGHTS * The global market for proteomics is expected to increase from $6.7 billion in 2008 to an estimated $7.9 billion in 2009 and $19.4 billion in 2014, for a compound annual growth rate (CAGR) of 19.7%. * Proteomics equipment was valued at $4.1 billion in 2008 and an estimated ...
Industries : Biotechnology
2009 Worldwide Biological Product Manufacturing Industry Report
- $ 249
- July 2009
The Worldwide Biological Product Manufacturing Industry report contains timely and accurate industry statistics, forecasts and demographics. The report features 2009 current and 2010 forecast estimates on the size of the industry (sales, establishments, employment) for the 47 largest world countrie ...
Industries : Biological Therapy
Competitor Analysis: Immunotoxins
- $ 188
- July 2009
Product description The present Competitive Intelligence Report about Immunotoxins provides a competitor evaluation in the field of tumor targeted toxins by means of antibodies or proteins for treatment of cancer as of July 2009. Immunotoxin therapy is a promising molecular canc ...
Industries : Biotechnology, Pharmaceutical
Global Top 10 Biotechnology Companies ? Industry, Financial and SWOT Analysis
- $ 1 895
- July 2009
Scope:?Top 10 Global Biotechnology Companies Report: Strategic evaluation of industry and key players? is a business report that provides a comprehensive view of the global biotechnology industry and its top 10 companies.The report includes the following:? Industry analysis including market value, m ...
Industries : Biotechnology
Sigma-Aldrich Corporation - SWOT Analysis
- $ 125
- June 2009
Datamonitor's Sigma-Aldrich Corporation - SWOT Analysis company profile is the essential source for top-level company data and information. Sigma-Aldrich Corporation - SWOT Analysis examines the company?s key business structure and operations, history and products, and provides summary analysis of i ...
Industries : Biotechnology, Healthcare
Biotechnology in Australia
- $ 737
- June 2009
Industry Market Research SynopsisThis Industry Market Research report provides a detailed analysis of the Biotechnology in Australia industry, including key growth trends, statistics, forecasts, the competitive environment including market shares and the key issues facing the industry.Industry Defi ...
Industries : Biotechnology
Oncology Partnering Agreements in Pharma, Biotech and Diagnostics
- $ 1 738
- June 2009
The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the worlds leading biopharma companies.Comprehensive directory of oncology deals since 2003 Oncology contra ...
Industries : Biotechnology, Pharmaceutical
Biotech Exit Strategies: Delivering value to investors in a challenging funding market
- $ 3 835
- June 2009
Biotechnology ventures involve costly research and development and a 10-20 year delay in generating product revenues. The high risk nature of early stage biotech research is primarily funded through venture capital, with high risks resulting in potentially high rewards. While the biotech venture mod ...
Industries : Biotechnology
Genentech, Inc. - Financial and Strategic Analysis Review
- $ 125
- June 2009
Genentech, Inc. - Financial and Strategic Analysis ReviewSummaryGenentech, Inc. (Genentech) is a biotechnology company focused on research and development, manufacturing, and marketing of biotherapeutics. Genentech is developing the drugs across the unmet medical needs in cancer, asthma and angiogen ...
Industries : Biotechnology
Nabi Biopharmaceuticals - Financial and Strategic Analysis Review
- $ 125
- June 2009
Nabi Biopharmaceuticals - Financial and Strategic Analysis ReviewSummaryNabi Biopharmaceuticals is a pharmaceutical company engaged in applying vaccine and antibody technologies to develop new products for unmet medical needs. It commercializes its products to dialysis centers, hospitals and physici ...
Industries : Biotechnology
Elan Corporation, plc - Financial and Strategic Analysis Review
- $ 125
- June 2009
Elan Corporation, plc - Financial and Strategic Analysis ReviewSummaryElan Corporation, plc (Elan) is an Irish based biotechnology company, incepted in 1969. The company is focused on the research, development, manufacturing and marketing of advanced therapies in neurology, autoimmune diseases and s ...
Industries : Biotechnology
GeoVax Labs, Inc. - Financial and Strategic Analysis Review
- $ 125
- June 2009
GeoVax Labs, Inc. - Financial and Strategic Analysis ReviewSummaryGeoVax Labs, Inc. (GeoVax) is a clinical stage biotechnology company focused on research and development activities with a goal to develop, license and commercialize human vaccines for diseases caused by Human Immunodeficiency Virus ( ...
Industries : Biotechnology
reportlinker.com © Copyright 2009. All rights reserved